APA Alıntı

Sagiv-Barfi, I., Kohrt, H. E. K., Czerwinski, D. K., Ng, P. P., Chang, B. Y., & Levy, R. (2015). Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK. Proc Natl Acad Sci U S A.

Chicago Stili Alıntı

Sagiv-Barfi, Idit, Holbrook E. K. Kohrt, Debra K. Czerwinski, Patrick P. Ng, Betty Y. Chang, ve Ronald Levy. "Therapeutic Antitumor Immunity By Checkpoint Blockade Is Enhanced By Ibrutinib, an Inhibitor of Both BTK and ITK." Proc Natl Acad Sci U S A 2015.

MLA Alıntı

Sagiv-Barfi, Idit, et al. "Therapeutic Antitumor Immunity By Checkpoint Blockade Is Enhanced By Ibrutinib, an Inhibitor of Both BTK and ITK." Proc Natl Acad Sci U S A 2015.